SCHEMBL24309752

SCHEMBL24309752

c1ccc(Oc2cc(-c3ccccc3)nc(NSc3ccccc3)n2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.57
TDP1 Q9NUW8 2/20 0.57
GPR39 O43194 1/20 0.47
CYP1A2 P05177 3/20 0.47
CYP2C9 P11712 3/20 0.47
CYP2C19 P33261 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
MAPT P10636 4/20 0.45
ALDH1A1 P00352 2/20 0.45
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
HPGD P15428 2/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
AGTR1 P30556 3/20 0.41
GLA P06280 1/20 0.39
POLB P06746 1/20 0.39
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310176 0.91 MAPK1 (0.51) MAPK1TDP1GPR39CYP1A2CYP2C9
SCHEMBL24310546 0.89 MAPK1 (0.49) MAPK1TDP1GPR39CYP1A2CYP2C9
SCHEMBL24310446 0.88 MAPT (0.46) MAPK1TDP1GPR39CYP1A2CYP2C9
SCHEMBL24309605 0.86 MCL1 (0.47) MAPK1TDP1GPR39CYP2C9CYP2C19
SCHEMBL24310597 0.84 TDP1 (0.44) MAPK1TDP1GPR39SMN1; SMN2MAPT
SCHEMBL24309688 0.84 MAPK1 (0.46) MAPK1TDP1GPR39CYP1A2CYP2C9
SCHEMBL11289134 0.83 AGTR1 (0.56) TDP1CYP1A2CYP2C9CYP2C19SMN1; SMN2
SCHEMBL24310009 0.83 GPR39 (0.45) MAPK1TDP1GPR39CYP1A2CYP2C9
SCHEMBL24309653 0.83 MAPK1 (0.51) MAPK1TDP1GPR39CYP1A2CYP2C9
SCHEMBL24310289 0.83 AGTR1 (0.46) MAPK1TDP1SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed